Asymptomatic hyperprolactinaemia due to macroprolactin, which is not bioactive in vivo, has prompted research on prolactin and the many commercially available immunoassays used to measure the hormone. Here, Veronique Jarrige provides an overview of implications for the laboratory.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.